Prescription Required
There is limited information available on the use of this medication.
There is limited information available on the use of this medication.
It is not known whether it is safe to consume alcohol with this medication.
It is not known whether this medication alters the ability to drive.
Information regarding the use of this medication during pregnancy is not available.
Information regarding the use of this medication during breastfeeding is not available.
Dacomitinib: Dacomitinib is a tyrosine kinase inhibitor that specifically targets and blocks the activity of the epidermal growth factor receptor (EGFR). EGFR is a protein that, when mutated, can promote the growth and spread of cancer cells.
Non-Small Cell Lung Cancer (NSCLC): NSCLC is the most common type of lung cancer, accounting for about 85% of all lung cancer cases. It includes several subtypes, such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
MBA in Pharmaceutical
Content Updated on
Thursday, 29 August, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA